Navigation Links
New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer
Date:5/30/2009

ing field of personalized medicine and in applying evidence-based protocols to elevate the practice of pharmacy -a key element in reforming America's health care system. Medco is ranked number 45 on the Fortune 500 list, with 2008 revenues of more than $51 billion. For more information about Medco, go to http://www.medcohealth.com.

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the risks and uncertainties that affect our business, particularly those mentioned in the Risk Factors section of the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission.


'/>"/>
SOURCE Medco Health Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. New Study: Pine Bark Significantly Reduces Menstrual Pain
2. New Study: Pine Bark Extract Boosts Nitric Oxide (NO) Production
3. New Research Shows Antidepressants May Thwart Breast Cancer Treatment
4. New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI)
5. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
6. New Studies Show Popular Heartburn Medications Moderate the Effect of Taking Widely Prescribed Heart Drug
7. Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery
8. VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
9. Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women
10. CVS Caremark Data Confirms Improved Outcomes for Women with Osteoporosis Who are Adherent to Therapy
11. Methadone Frequently Causes Menopausal Symptoms in Young Women

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...FORD, Mass., Nov. 25 Hol... ), a leading developer, manufacturer and supplier...nd surgical products dedicated to serving the heal... of the Radiological Society of North America (RSN...ugh December 3, 2009 to highlight our new SecurVie...
(Date:11/25/2009)...HILADELPHIA, Nov. 25 ERT...l J. McKelvey, the Company,s President and CEO, an...ident and CFO, are scheduled to present at the 21s...:30 PM EST on December 1, 2009 in New York City, N...resentation by visiting the Company,s corporate we...
(Date:11/25/2009)..., Pa., Nov. 25 BioTrends Research ...TM) : Stelara report, the first in a multi-ph...e launch of Centocor Ortho-Biotech,s Stelara, from...ailability. Each wave of the report provides quan... and qualitative information from a subset of 20. ...
Breaking Medicine Technology:New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call 12831 1Younger People Appear More at Risk From New Swine Flu 50334 1Younger People Appear More at Risk From New Swine Flu 50334 2Younger People Appear More at Risk From New Swine Flu 50334 3Younger People Appear More at Risk From New Swine Flu 50334 4TAHU Takes on New Leadership During Vital Time in Health Insurance Industry 50330 1TAHU Takes on New Leadership During Vital Time in Health Insurance Industry 50330 2
...l target in inflammatory indications...ril 15 Roche announced today that it,will acquire...using on,therapeutics targeting PI3-kinase (PI3-K)...role in disease progression and in resistance to,c...dies have demonstrated,the activity of PI3-K inhib...
...rhythms, TAMPA, Fla., April 15 Stinger Systems, ...ro-stun technology today,announced that an animal ...as presented at the 2008 Rocky Mountain Bioenginee...e full paper is available for purchase from the,co...://www.rmbs.org , ABOUT STINGER SYSTEMS, Stinger...
Other Medicine Technology:Roche Gains Access to Important Oncology Target With Potential for Treating Major Cancers Such as Breast and Lung; First Drug Candidate in Phase I Clinical Testing 2Roche Gains Access to Important Oncology Target With Potential for Treating Major Cancers Such as Breast and Lung; First Drug Candidate in Phase I Clinical Testing 3Roche Gains Access to Important Oncology Target With Potential for Treating Major Cancers Such as Breast and Lung; First Drug Candidate in Phase I Clinical Testing 4
(Date:11/27/2009)... Uploadable USB pedometers may be new, but they,re...ion of advanced accelerometer functionality and au...n over the accuracy of self-reported data. It,s no... participation in a fitness program. ,, CoreHea...liers to integrate this technology. "Our health ch...
(Date:11/27/2009)...FirstCall/ -- The Gymboree Corporation (Nasdaq: G...present at the NASDAQ OMX 23rd Investor Program, w... England, on Wednesday, December 2, 2009, at 11:45...The Gymboree Corporation,s presentation over the I...on "Our Company" at the bottom of the page, go to ...
(Date:11/27/2009)...Newswire-FirstCall/ -- Shamir Optical Industry Ltd...r of innovative products and technology to the oph...d of directors had declared a dividend distributio...imately NIS 37.62 million based on the November 25...imately US$ 0.609 (approximately NIS 2.3 based on ...
(Date:11/27/2009)...economic burdens, study predicts , , FRI...ple with diabetes in the United States is expected...dicts. , That would bring the total by 2034 to ...m 23.7 million today. , , At the same time, the ... the study also warns, rising from an estimated $1...
(Date:11/27/2009)...ual coloring books designed for children ages 2 to... educate - inform parents and children alike on a ...s to ABC,S and a host of other topics. , ...7, 2009 -- Today’s children have enough gadg...r of the day, but one of the oldest and simplest a...
Breaking Medicine News(10 mins):Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2
.... (OTC Bulletin Board: NILT.OB), a biopharmaceutic...diovascular disease, is pleased to announce the,ap... President of,Regulatory Affairs., "We believe Ja...kground will be of great value to Nile as we devel...
...on pharmaceuticals in water, LISLE, Ill., May 8 ...verning drinking water are not strict,enough, acco...he Water,Quality Association. The release of these...te has begun public hearings,to look into the issu...
...ladelphians are expected to join the Lupus WHAT: ...h live entertainment, information and refr...eness about lupus. Live music, giveaways, snacks ...ne., WHY: Although first recognized by medical ...
...,(Nasdaq: DIET ), leveraging the power of the Int... solutions to everyone, today announced that it wi...h 31, 2008, after the U.S.,equity markets close on...ern Time.,Participants may access the call by dial...
...ansmission of patient data from ...PAWTUCKET, R.I., May 8 /PRNewswire/,--InterCompone...nology,solutions and Memorial Hospital of Rhode Is...r Primary Care and Prevention,which tests an eHeal...
... recognizes innovative product launch...8 Mangos, a full-service advertising,agency, took...Advertising,Award competition, sponsored by the He...d from a field of over 4400 entries, Mangos captur...
Other Medicine News:Health News:Jane Moffitt, J.D., LL.M. Named Vice President of Regulatory Affairs of Nile Therapeutics 2Health News:Jane Moffitt, J.D., LL.M. Named Vice President of Regulatory Affairs of Nile Therapeutics 3Health News:Half of Americans Want Stricter Water Quality Laws, Survey Finds 2Health News:5th Annual World Lupus Day Philadelphians Take Part In a Global Rally of Support 2Health News:eDiets.com(R) to Report First Quarter 2008 Results on Tuesday, May 13, 2008 2Health News:InterComponentWare Inc. and Memorial Hospital of Rhode Island Celebrate Milestone 2Health News:InterComponentWare Inc. and Memorial Hospital of Rhode Island Celebrate Milestone 3Health News:InterComponentWare Inc. and Memorial Hospital of Rhode Island Celebrate Milestone 4Health News:Mangos Captures 11 HMR Awards 2
Gibco Gentamicin Reagent Solution (50 mg/ml), liquid
LB Agar Plates Magnesium Sulfate-10
LB Agar
L-BROTH, liquid, 5 g NaCl
Medicine Products: